Home › Health › Li Ka-shing funds Asia’s first non-invasive kidney...
Health

Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong

Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
Key Points

Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions.

Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a technology that uses focused sound waves to break apart tumours without surgical incisions. The trials...
Li Ka-shing (PERSON) Asia (LOCATION) Hong Kong (LOCATION) The Li Ka Shing Foundation (PERSON) CUHK Medical Centre (ORG) Gleneagles Hospital Hong Kong (ORG) Hong Kong Sanatorium & Hospital (LOCATION)
Originally published by South China Morning Post Read original →